These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16416180)

  • 1. A higher dose requirement of tacrolimus in active Crohn's disease may be related to a high intestinal P-glycoprotein content.
    Buchman AL; Paine MF; Wallin A; Ludington SS
    Dig Dis Sci; 2005 Dec; 50(12):2312-5. PubMed ID: 16416180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus for Crohn's disease.
    Ruddock B
    Issues Emerg Health Technol; 2006 Sep; (88):1-4. PubMed ID: 16981314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory enterovesical and duodenocolic fistulas in Crohn's disease successfully managed with tacrolimus.
    Fukuda A; Nakase H; Seno H; Nabeshima M; Sawada M; Chiba T
    J Gastroenterol; 2005 Apr; 40(4):433-5. PubMed ID: 15870981
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral tacrolimus treatment of severe colitis in children.
    Bousvaros A; Kirschner BS; Werlin SL; Parker-Hartigan L; Daum F; Freeman KB; Balint JP; Day AS; Griffiths AM; Zurakowski D; Ferry GD; Leichtner AM
    J Pediatr; 2000 Dec; 137(6):794-9. PubMed ID: 11113835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficiency of tacrolimus therapy for perianal Crohn's disease].
    Nanaeva BA; Vardanyan AV; Khalif IL
    Ter Arkh; 2015; 87(6):83-87. PubMed ID: 26281201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's-like colitis in a patient with immunodeficiency associated with a defect in expression of inducible costimulator.
    Mudter J; Wirtz S; Weigmann B; Tiede I; Tubbe I; Kiesslich R; Galle PR; Lehr HA; Neurath MF
    Dig Dis Sci; 2006 Apr; 51(4):711-7. PubMed ID: 16614993
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of a Crohn's disease-related cutaneous facial lesion with topical tacrolimus.
    Shah NP; Goel RM; Escudier M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):e71-3. PubMed ID: 25151593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterobiasis mimicking Crohn's disease.
    Fernandez-Flores A; Dajil S
    Indian J Gastroenterol; 2004; 23(4):149-50. PubMed ID: 15333976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ; Tremaine WJ; Lawson GM
    Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus for recurrent penile Crohn's disease.
    Sánchez L; Cabanillas M; Alvarez JC; Echarri A
    J Crohns Colitis; 2014 Oct; 8(10):1145-6. PubMed ID: 24815787
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased drug penetration in inflamed tissue related to changed mucosal metabolism in experimental colitis.
    Pellequer Y; Weissenborn V; Lamprecht A
    J Pharm Sci; 2007 Aug; 96(8):2145-53. PubMed ID: 17542013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease.
    Tamaki H; Nakase H; Matsuura M; Inoue S; Mikami S; Ueno S; Uza N; Kitamura H; Kasahara K; Chiba T
    J Gastroenterol; 2008; 43(10):774-9. PubMed ID: 18958546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
    Ogata H; Matsui T; Nakamura M; Iida M; Takazoe M; Suzuki Y; Hibi T
    Gut; 2006 Sep; 55(9):1255-62. PubMed ID: 16484504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Ling C; Gavin M; Hanson J; McCarthy DM
    Dig Dis Sci; 2018 Jul; 63(7):1751-1755. PubMed ID: 29934698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic Crohn's disease: two cases of penile Crohn's and literature review.
    Lane VA; Vajda P; King D; Stahlschmidt J; Sugarman I; Subramaniam R
    J Pediatr Urol; 2010 Jun; 6(3):270-3. PubMed ID: 19800295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
    Yigitaslan S; Erol K; Cengelli C
    Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.